Strategies for typhoid conjugate vaccines in endemic nations - Authors' reply

Affiliations

¹ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
² Oxford Vaccine Group, Department of Paediatrics, University of Oxford; NIHR Oxford Biomedical Research Centre, Oxford, UK.
³ Center for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, 2610 Antwerp, Belgium. Electronic address: joke.bilcke@uantwerp.be.

Comment

Virginia E Pitzer et al. Lancet Infect Dis. 2021 Mar.

. 2021 Mar;21(3):321-322.

doi: 10.1016/S1473-3099(21)00018-9.

¹ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA.
² Oxford Vaccine Group, Department of Paediatrics, University of Oxford; NIHR Oxford Biomedical Research Centre, Oxford, UK.
³ Center for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, 2610 Antwerp, Belgium. Electronic address: joke.bilcke@uantwerp.be.

No abstract available

Comment on

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
Bilcke J, Antillón M, Pieters Z, Kuylen E, Abboud L, Neuzil KM, Pollard AJ, Paltiel AD, Pitzer VE. Bilcke J, et al. Lancet Infect Dis. 2019 Jul;19(7):728-739. doi: 10.1016/S1473-3099(18)30804-1. Epub 2019 May 23. Lancet Infect Dis. 2019. PMID: 31130329 Free PMC article.
Strategies for typhoid conjugate vaccines in endemic nations.
Kalule JB. Kalule JB. Lancet Infect Dis. 2021 Mar;21(3):320-321. doi: 10.1016/S1473-3099(20)30945-2. Lancet Infect Dis. 2021. PMID: 33639122 No abstract available.